These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7924573)

  • 21. The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
    Flapan AD; Davies E; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1992 Jul; 13(7):971-5. PubMed ID: 1644090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The hemodynamic effects of captopril].
    Chen MX
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Sep; 13(4):241-5, 317. PubMed ID: 3015544
    [No Abstract]   [Full Text] [Related]  

  • 23. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Nussberger J
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):169-75. PubMed ID: 1376784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of captopril in the treatment of patients with severe forms of chronic heart failure].
    Irani RM
    Ter Arkh; 1986; 58(11):55-8. PubMed ID: 3547747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril (Tensiomin) in the treatment of chronic heart failure of ischaemic heart disease patients.
    Palócz E; Kerkovits G
    Ther Hung; 1989; 37(4):220-4. PubMed ID: 2698519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ; Laragh JH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Favorable hemodynamic effects of captopril in chronic refractory congestive heart failure].
    Ansalone G; Bellocci F; Scabbia E; Schiavoni G; Loperfido F; Zecchi P
    Cardiologia; 1982; 27(3):263-9. PubMed ID: 6765431
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term treatment of severe cardiac failure with captopril (author's transl)].
    Komajda M; Eugène M; Evans J; Lecossier D; Grosgogeat Y
    Nouv Presse Med; 1981 Apr; 10(19):1587-90. PubMed ID: 7025850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renin-angiotensin system antagonists].
    Ogawa M; Inagaki Y
    Nihon Rinsho; 1983 Dec; 41(12):2703-8. PubMed ID: 6371300
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
    Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G
    J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous captopril in congestive heart failure.
    Ahmad S; Giles TD; Roffidal LE; Haney Y; Given MB; Sander GE
    J Clin Pharmacol; 1990 Jul; 30(7):609-14. PubMed ID: 2202753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.